ANIMALCARE GROUP PLC Logo

ANIMALCARE GROUP PLC

Develops & sells veterinary prescription & OTC medicines for professionals worldwide.

ANCR | IL

Overview

Corporate Details

ISIN(s):
GB0032350695
LEI:
213800A7XPQ528RMCC72
Country:
United Kingdom
Address:
MOORSIDE, YO32 9LB YORK
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Animalcare Group plc is an international veterinary pharmaceutical company that develops, commercializes, and markets products to support animal health and wellbeing. Serving the veterinary profession, its portfolio includes licensed prescription and over-the-counter medicines. The company's growth strategy centers on expanding its product pipeline through a combination of in-house development, strategic acquisitions of products and businesses, and in-licensing of early and late-stage innovations. Animalcare actively pursues commercial partnerships to drive geographic expansion, maintaining a direct presence in seven European countries and exporting to over 40 markets worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-23 08:00
Report Publication Announcement
Notice of Results & Presentations
English 16.0 KB
2025-08-22 08:00
M&A Activity
Acquisition of VHH NGF programme & related assets
English 16.3 KB
2025-07-24 08:00
Earnings Release
H1 Trading Update and Notice of Results
English 25.2 KB
2025-06-13 08:42
M&A Activity
Strategic investment in Australian business
English 22.3 KB
2025-06-10 17:36
Post-Annual General Meeting Information
Result of 2025 AGM
English 35.5 KB
2025-05-30 08:00
Share Issue/Capital Change
Exercise of Options and Total Voting Rights
English 12.2 KB
2025-05-23 10:21
Major Shareholding Notification
Notification of Major Holding in Company
English 24.3 KB
2025-05-16 08:00
Report Publication Announcement
2024 Annual Report and Notice of 2025 AGM
English 9.7 KB
2025-04-22 14:23
Major Shareholding Notification
Notification of Major Holding in Company
English 22.2 KB
2025-01-23 08:00
Earnings Release
2024 Full Year Trading Update
English 11.9 KB
2025-01-20 08:00
Declaration of Voting Results & Voting Rights Announcements
Exercise of Options and Total Voting Rights
English 10.3 KB
2025-01-03 11:12
M&A Activity
Completion of Randlab acquisition
English 9.2 KB
2025-01-02 11:11
Declaration of Voting Results & Voting Rights Announcements
Notification of Total Voting Rights
English 10.2 KB
2024-12-10 08:00
Board/Management Information
Appointment of Alternate Director
English 20.4 KB
2024-12-06 16:44
Major Shareholding Notification
Notification of Major Holding in the Group
English 23.1 KB

Automate Your Workflow. Get a real-time feed of all ANIMALCARE GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ANIMALCARE GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA

Talk to a Data Expert

Have a question? We'll get back to you promptly.